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In the majority of patients with Pelizaeus-Merzbacher disease, duplication of the proteolipid protein gene PLP1 is
responsible, whereas deletion of PLP1 is infrequent. Genomic mechanisms for these submicroscopic chromosomal
rearrangements remain unknown. We identified three families with PLP1 deletions (including one family described
elsewhere) that arose by three distinct processes. In one family, PLP1 deletion resulted from a maternal balanced
submicroscopic insertional translocation of the entire PLP1 gene to the telomere of chromosome 19. PLP1 on the
19qtel is probably inactive by virtue of a position effect, because a healthy male sibling carries the same der(19)
chromosome along with a normal X chromosome. Genomic mapping of the deleted segments revealed that the
deletions are smaller than most of the PLP1 duplications and involve only two other genes. We hypothesize that
the deletion is infrequent, because only the smaller deletions can avoid causing either infertility or lethality. Analyses
of the DNA sequence flanking the deletion breakpoints revealed Alu-Alu recombination in the family with trans-
location. In the other two families, no homologous sequence flanking the breakpoints was found, but the distal
breakpoints were embedded in novel low-copy repeats, suggesting the potential involvement of genome architecture
in stimulating these rearrangements. In one family, junction sequences revealed a complex recombination event.
Our data suggest that PLP1 deletions are likely caused by nonhomologous end joining.
Introduction
The proteolipid protein gene (PLP1) is a dosage-sensitive
gene located on chromosome Xq22.2. An extra copy of
the PLP1 gene, resulting from large genomic duplications
containing the entire gene, affects development of the oli-
godendrocytes in the CNS and results in a dysmyelinat-
ing disease, Pelizaeus-Merzbacher disease (PMD [MIM
312080]; Ellis and Malcolm 1994; Inoue et al. 1996,
1999). PMD is characterized by arrest of oligodendrocyte
differentiation and failure to produce myelin in the CNS,
resulting in developmental delay recognized from the first
year of life in most patients (Hudson 2001). Patients with
PMD also present with additional neurological features,
including nystagmus, pyramidal and extrapyramidal
signs, and cerebellar symptoms. Although PLP1 dupli-
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cations account for the majority of PMD (60%–70% of
patients), sequence alterations in the coding regions and
splice site junctions of PLP1 also cause PMD (∼20%)
(Garbern et al. 1999). Deletion of PLP1 can also result
in PMD, although only one family has been described to
date (Raskind et al. 1991).
Molecular characterization of PLP1 duplication re-
vealed that unequal sister-chromatid exchange is prob-
ably the mechanism for genomic rearrangement (Wood-
ward et al. 1998; Inoue et al. 1999). During such re-
combination events in germ cells, reciprocal deletion of
the same genomic segments may be generated. However,
in a clinical setting, PLP1 deletion has been observed
infrequently compared with duplication. Also, in PMD,
the sizes of the duplicated genomic segments show ex-
tensive variability, distinct from other genomic disorders
involving duplication, such as Charcot-Marie-Tooth
disease type 1A and dup(17)(p11.2p11.2) (Stankiewicz
and Lupski 2002a, 2002b). These observations suggest
that the mechanisms for PLP1 genomic rearrangements
may differ from nonallelic homologous recombination
(NAHR) at paralogous low-copy repeats (LCRs) as
shown for recurrent genomic disorders (Inoue and Lup-
ski 2002; Stankiewicz and Lupski 2002a, 2002b).
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We studied three independent families with PLP1 de-
letions, including one family described elsewhere (Ras-
kind et al. 1991). Analyses in family members dem-
onstrated that the deletions arose by three distinct
processes: (i) unbalanced inheritance of an insertional
translocation, (ii) sister-chromatid exchange in male
meiosis, and (iii) complex rearrangement, but each ap-
peared to occur by nonhomologous end joining (NHEJ).
Genomic characterization of the deleted segments and
recombination products revealed the molecular mech-
anisms for the genomic rearrangements resulting in the
deletions and provided a potential explanation for the
infrequent observation of PLP1 deletion.
Patients and Methods
Family HOU542
Patient BAB1379 is a 10-year-old Japanese son of non-
consanguineous parents. There were no problems during
the pregnancy and delivery. Nystagmus was noted at the
age of 1 mo but later disappeared. Delay in his motor
development was noted at 6 mo of age. He rolled over
at 12 mo, held his head at 15 mo, and sat at 24 mo of
age. Spasticity became evident, particularly in his lower
extremities, at 18 mo. He could walk with support at
age 3 years, but subsequently his motor function grad-
ually declined. T2-weighted brain MRIs revealed sym-
metric, diffuse high intensity in the cerebral whitematter,
suggesting dysmyelination. Brainstem auditory evoked
potentials were abnormal. He had normal results in lab-
oratory investigations, including normal 46,XY G-
banded chromosomes. He has mildly reduced nerve-con-
duction velocities (36 m/s in median nerve), with no
apparent features of peripheral neuropathies, although
this could be masked by severe spasticity and muscle
atrophy secondary to disuse. At present, he is wheel-
chair-bound because of the prominent spasticity. He
feeds himself with assistance but requires full support
for most of his daily care. He has a healthy male sibling
(BAB1380).
His mother (BAB1381) presented with progressive dif-
ficulty in walking from her third decade. Subsequently,
spasticity and changes in her personality were noted.
Mental deterioration was gradually apparent. Because
of the worsening spasticity in her lower extremities, she
is wheelchair-bound. Her head MRI showed abnormal
changes in the cerebral white matter. Results of her lab-
oratory investigations and G-banded chromosome anal-
ysis were normal.
Family HOU669
Patient BAB1684, a 10-year-old son of unrelated
white parents, was born at term after an uneventful preg-
nancy and delivery. By 12 mo of age, he showed global
developmental delay. At 18 mo, he was still unable to
sit unsupported or roll over and had no intelligible
speech; however, he was sociable and enjoyed good gen-
eral health. He showed generalized spasticity, particu-
larly in the lower extremities. No history of abnormal
eye movements was noted. Over the next few years he
became able to speak in sentences, although he was dy-
sarthric. At age 5 years, brain MRI showed delayed my-
elination throughout the cerebrum; results of nerve-
conduction studies and electroencephalography were
normal. He was never able to walk unsupported, and
by age 7 years, he was confined to a wheelchair because
of severe spasticity. His speech showed marked dysar-
thria and slowing. He could feed himself without diffi-
culty in swallowing. No involuntary movement or
tremor was noted. Follow-up MRI revealed progressive
abnormalities in cerebral white matter, particularly
marked in the internal capsules and periventricular and
subcortical regions. At age 10 years, brainstem auditory
and somatosensory evoked potentials were abnormal,
and peripheral nerve-conduction velocities were at the
lower limit of normal (46.9 m/s). By this age, he was
totally dependent on others for feeding and personal
hygiene. An ophthalmoscopic examination revealed
marked optic atrophy. He has never experienced any
seizures.
His 32-year-old mother (BAB1699) denied any sig-
nificant medical problems. However, neurological ex-
amination revealed bilateral pes cavus deformities of the
feet, increased deep tendon reflexes, andmildly increased
muscle tone in the lower extremities, although Babinski
reflexes were negative. She was unable to perform tan-
dem gait. The remainder of the examination was un-
remarkable. Patient BAB1684 has a healthy female sib-
ling (BAB1701).
Family PMD1
This family was originally described by Raskind et al.
(1991). We obtained lymphoblastoid cell lines from two
patients (H142 and H152) and a carrier female (H150),
which were used for molecular studies.
Interphase and Metaphase FISH
Informed consent was obtained from each patient and
family member. Harvested lymphoblastoid cells estab-
lished from patients and family members were dropped
on a glass slide for interphase and metaphase FISH anal-
yses, as described elsewhere (Shaffer et al. 1997). Probes
used in the interphase FISH include PLP1 (cosmid
c125A1), DXS8096 (RP1-34H10), DXS8075 (RP1-
81E11), and the BTK intrachromosomal control probe
(RP1-39B6), as described elsewhere (Inoue et al. 1999).
For metaphase FISH probes, we used a chromosome
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19ptel–specific probe (Vysis) and PLP1 (cosmid
c125A1).
Southern Hybridization
We digested 5 mg of genomic DNA from family mem-
bers of HOU542 with each of the following restriction
endonucleases: BamHI, PstI, HindIII, and XbaI, electro-
phoresed on 1% agarose gel and transferred to a nylon
membrane after denaturation. Probe u35G3.20Kwas ob-
tained by PCR from genomic sequences of the proximal
boundary of the deleted region (primer u35G3.20K-U, 5′-
GGCTGGGTCTCTTTTTCTAC-3′; and u35G3.20K-L,
5′-GGGGACAATGATGCTTACGA-3′) and used for
hybridization.
PCR Amplification of the PLP1 Exons and STS Markers
Genomic DNA was extracted from peripheral blood
cells and/or lymphoblastoid cells. Each exon of the PLP1
gene was amplified, with these genomic DNAs as the
template (Osaka et al. 1999). We used STSs adjacent to
the PLP1 locus, including DXS8096, SG45649,
SG45650, DXS1191, and DXS8075, for STS-content
mapping of the deletion. Additional primers for STSs
were identified from genome mapping and sequence da-
tabases as well as PAC end-sequencing analyses, to fur-
ther narrow down the recombination breakpoints by
STS-content mapping (Tp-A, 5′-CCACTCCCTTTCTG-
CTTCACTGCTC-3′ and 5′-GGTCCTGGCAAACCCTT-
TCATCAGC-3′; Tp-B, 5′-CCAATGCAAAGACCAACA-
CT-3′ and 5′-GGAGCAGAAAGAAACTATCA-3′; Td-A,
5′-TGTTGACAAGGCTTCAGTAT-3′ and 5′-AGGCAC-
TTTTTAGTTAGGAG-3′; Td-B, 5′-GTCCTCAATGCT-
GTAATCCC-3′ and 5′-GAAATCCAATTAAGTTCTGT-
ATTT-3′; Gp-A, 5′-GAGATTAAGCCATTTTCCAT-3′
and 5′-GCTTTTACATGACCAGACTA-3′; Gp-B, 5′-GC-
TCTGTAAGGCTAAATGTT-3′ and 5′-TGAACTTGGG-
CTGGTGGTAT-3′; Gd-A, 5′-CCAACATCACTTATTC-
ACCA-3′ and 5′-CCACTTCTCACCCATCTCAG-3′; Gd-
B, 5′-CTGGAACTTGGGAGGTGACC-3′ and 5′-GGCA-
AGAAAGGGACTGACTG-3′; Wp-A, 5′-TTAGTTGCC-
TGCCCTGATGA-3′ and 5′-TCCTTCTGCCCTCTGTG-
TGG-3′; Wp-B, 5′-CCAGAAAAGGGTCAGAGAGG-3′
and 5′-TGGAGCAAGCAGAACAAATG-3′; Wd-A, 5′-C-
TGGAACTTGGGAGGTGACC-3′ and 5′-GCTGTGAC-
CGTTTCTTCATT-3′; Wd-B, 5′-TAATGCAGCTCAAA-
GGAAAG-3′ and 5′-CAGGGACATAAATCTCAATC-
3′). The PCR products were electrophoresed on 2%
agarose gels, and ethidium bromide staining was per-
formed for visualization.
X-Inactivation Studies
We tested for random X inactivation, using a PCR-
based assay with slight modifications (Allen et al. 1992).
Genomic DNA was digested with the methylation-sen-
sitive restriction endonuclease HpaII and was amplified
with a set of fluorescently labeled primers from the an-
drogen-receptor gene (AR) (Allen et al. 1992). PCR
products were analyzed by an ABI 377 automated se-
quencer, with Genescan software (Applied Biosystems)
for haplotyping and signal quantification.
Haplotype Analysis
We used four fluorescence-labeled primers for STR
markers—DXS8096, CA-PLP (Mimault et al. 1995),
DXS1191, and DXS8075—to determine the haplotype
of family members from HOU669. To examine recom-
binations within an interval between AR and PLP1, we
used seven STR markers that span these two genes
(DXS991-AR-DXS986-DXS990-DXS8077-DXS8020-
DXS1106-PLP1-DXS8075). PCR products were sepa-
rated by electrophoresis, using an ABI 377 (Applied
Biosystems), and were analyzed by the appropriate soft-
ware, Genescan and Genotyper (Applied Biosystems).
Degenerate Oligonucleotide Primer (DOP) PCR for
Junction Fragment Cloning
We used DOP-PCR to span the recombination break-
point and to obtain DNA sequence of the junction frag-
ment for each deletion. A pair of oligonucleotide prim-
ers, remote and nested, was designed from the proximal
side of the breakpoint for each family (u36G3.20.1K-U,
5′-CCACTCCCTTTCTGCTTCACTGCTC-3′, and
u36G3.20.1K-N, 5′-TGCTGATGAAAGGGTTTGCC-
AGGAC-3′ for family HOU542; GproxDOP.R182, 5′-
GCAGGAAGAGAAGCACAGGCAAAGGGAGTA-3′,
and GproxDOP.N289, 5′-CTAATGACAGAGGACAC-
CAGGGAGCAGAAT-3′ for family HOU699; and
WproxDOP.R49, 5′-GACTCCTATTAGTTGCCTGCC-
CTGATGAGG-3′, and WproxDOP.N195, 5′-AGTGCT-
GCTTGTGCTGGCTCCAATGCTGTG-3′ for family
PMD1). We used a degenerate primer, 6MW (5′-CCGA-
CTCGAGNNNNNNATGTGG-3′), in the primer exten-
sion and after PCR amplification, as described elsewhere
(Wu et al. 1996), with slight modification. After the se-
quential PCR using the remote/6MW and nested/6MW
primer sets, we separated PCR products by agarose gel
electrophoresis. A second round of PCR products was
purified and sequenced directly. On the basis of the se-
quence data, we designed primers flanking the break-
points to amplify deletion-specific junction fragments, to
confirm the results from the DOP-PCR analyses (Tjct,
5′-CCACTCCCTTTCTGCTTCACTGCTC-3′ and 5′-
GGAGCAGAAAGAAACTATCA-3′; Gjct, 5′-CACAG-
ACTTCACTTGGAATG-3′ and 5′-CCATTTGAAAAC-
ATAAGCAA-3′; Wjct, 5′-AGTGCTGCTTGTGCTGG-
CTCCAATGCTGTG-3′ and 5′-TAAGTCGTTTCTAT-
TTTGAGTTCCTTCTTG-3′). The following primer set
was used to investigate the possibility of an inversion
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rearrangement in family PMD1 (breakpoint PCR, 5′-
TCCAAAGGAGAAAGCAACCACAGAT-3′ and 5′-CC-
CAGAATATTTACCAACAGAGGAG-3′).
Genome Sequence Analyses of the PLP1 Region
A 1.5-Mb genomic segment flanking PLP1 was ob-
tained from the University of California, Santa CruzHu-
man Genome Project Working Draft. Genes and pre-
dicted genes in the region were identified with an
integrated Web-based homology search and annotation
tool, BLAT (Kent 2002), and a genome sequence–
annotation database, Ensembl (Hubbard et al. 2002).
Genome sequence was locally assembled with Se-
quencher (Genecode) sequence analysis software. Each
predicted gene in the Ensembl database was evaluated
individually for possible coding sequence, existence of
ESTs with perfect sequence match, and similarity to
other genes, using various Web-based sequence analysis
software including RepeatMasker, BLAST, Fgenesh,
Grail, and MZEF, as described elsewhere (Inoue et al.
2001a). PipMaker with Dotplot analyses was used to
identify potential LCRs in this region (Schwartz et al.
2000). The sequences of potential LCRs were analyzed
for identity with each other by BLAST2.
Results
Deletion of the Entire PLP1 Gene
Interphase FISH using a PLP1 probe revealed that the
patients from all three families (BAB1379, BAB1684,
and H142) carried deletion of the PLP1 gene (fig. 1).
However, probes for two markers that flank PLP1 (RP1-
34H10, distal to DXS8096, and RP1-81E11, for
DXS8075) exhibited a normal pattern of hybridization
signals (fig. 1), indicating that these deletion rearrange-
ments are smaller than those usually observed with
PMD-associated duplications (Inoue et al. 1999).
PCR analyses did not amplify PLP1 exonic sequences
in any of the three male probands. Subsequent STS-con-
tent mapping revealed that all deletion segments are
flanked by DXS8096 and DXS8075, confirming the re-
sults from interphase FISH analyses. STS mapping with
SG45649, SG45650, andDXS1191 showed that the de-
leted segments in these three families are of different
sizes. Together with a normal karyotype for the three
male patients (data not shown), our data suggest that
each patient has a submicroscopic deletion of PLP1, but
distinct genomic segments are involved.
Interstitial Translocation of the PLP1 Gene in Family
HOU542
Genomic Southern blotting analysis of family
HOU542, using a probe from the X chromosome, re-
vealed deletion-specific junction fragments in genomic
DNA from the proband (BAB1379) and his mother
(BAB1381) (fig. 2). These data indicate that the deleted
X chromosome was inherited from the mother. The pro-
band’s healthy brother (BAB1380) does not have this
junction fragment, which indicates that he does not carry
the deleted X chromosome.
Interphase FISH analyses of BAB1381 showed two
PLP1 signals (red) and two intrachromosomal control
signals (green), but one PLP1 signal appeared to be dis-
tant from the control signal (fig. 3A). Metaphase FISH
showed one PLP1 signal on chromosome 19qtel (fig.
3B). These observations suggest that the submicroscopic
PLP1 deletion in BAB1379 resulted from inheritance of
an unbalanced translocation. The patient BAB1379 did
not inherit the derivative chromosome 19 (no PLP1 sig-
nal was observed in either FISH or PCR analysis; fig.
1). However, to our surprise, his healthy male sibling,
BAB1380, carries this derivative chromosome 19, con-
taining PLP1 (fig. 3C). Thus, he carries two copies of
PLP1: one on his X chromosome and the other on one
chromosome 19 [46,XY.ish der(19)ins(19;X)(q13.4;
q22.2q22.2)(PLP1)].
Meiotic Recombination in the Maternal Grandfather
Generated the Deletion in Family HOU669
Interphase FISH analyses in family HOU669 revealed
that the patient’s healthy sister and mother are carriers
for the deletion. Both maternal grandparents had normal
FISH results from their blood cells and have no neu-
rological phenotype, indicating de novo rearrangement
in the mother. Haplotype analyses of the family mem-
bers, using four STR markers flanking PLP1 (DXS9096,
CA-PLP, DXS1191 and DXS8075), showed that the
deleted X chromosome in the patient was derived from
his maternal grandfather’s X chromosome. Because the
grandfather’s somatic cells do not have a deletion, our
findings suggest that the deletion event occurred in the
grandfather’s germ cells (fig. 4).
Slightly Skewed X Inactivation in HOU542 and
HOU669
In unaffected females, the X-inactivation pattern is rep-
resented by a “bell-shaped” distribution with a 50:50
average ratio for the active versus inactiveX chromosome,
respectively. Therefore, a skewed inactivation pattern is
not uncommon in unaffected females. In fact, a ratio of
80:20 can be observed in 5%–10% of unaffected fe-
males (Willard 2001). This skewingmay result in a disease
phenotype when one has a deleterious mutation in a gene
that is usually subjected to X inactivation.
In family HOU542, the mother (BAB1381) revealed
slightly skewed X inactivation (active vs. inactive X
chromosome 81:19) in the white blood cells (data not
shown). Haplotype analysis of family members, using
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Figure 1 Detection of PLP1 deletion and breakpoint mapping by STS-content mapping and interphase FISH analyses. Map (top) shows
selected STS markers surrounding the PLP1 locus that were used in this study. Results of agarose gel electrophoresis of PCR products for each
STS-PCR of a normal control are shown below. Probes used in the interphase FISH studies were assigned with corresponding color in the
photograph. The green probe, RP1-39B6, was used as an intrachromosomal control. Results for one proband from each family are shown.
Interphase FISH using u125A1 that contains the entire PLP1 gene (middle column) revealed no red signal in each patient, whereas interphase
FISH using RP1-34H10 and RP1-81E11 (left and right columns) reveal signals for markers proximal and distal to the breakpoints for the
deletion, respectively. Accordingly, agarose gel electrophoresis analyses (right column) of STS-content PCR products for each patient revealed
no amplification from STSs in the deleted segment, including PLP1 exonic sequences. STS-content-mapping analyses revealed distinct locations
for the deletion breakpoints in each family.
STRmarkers between Xq13.1 (AR) and Xq22.2 (PLP1),
showed that the 81% represents the chromosome bear-
ing the deleted allele (data not shown). Similarly, in fam-
ily HOU669, the mother (BAB1699) showed slight
skewing (82:18), and the carrier sister (BAB1701) re-
vealed essentially random inactivation (66:34; data not
shown). Haplotype analysis demonstrated a recombi-
nation between DXS8077 and DXS8020 in the patient,
and thus the deletion allele is represented by 82% and
66% in the mother and sister, respectively (data not
shown). In family PMD1, a carrier female, H150, re-
vealed random inactivation (41:59), with the former
number representing the deletion allele based on hap-
lotype analysis (data not shown).
Mapping of the Recombination Breakpoints and
Cloning of the Junction Fragments
Using STS markers that map to the PLP1 region, we
characterized the size of the deleted genomic segments
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Figure 2 Southern analysis identified a recombination-specific
junction fragment in family HOU542. Genomic DNA from proband
(BAB1379; lane 1), mother (BAB1381; lane 2), healthy male sibling
(BAB1380; lane 3), normal control (lane 5), and two patients with
PLP1 duplication (lanes 5 and 6) were used for genomic Southern
hybridization analysis using four different endonucleases.We observed
deletion-specific junction fragments (arrowheads) in the patient and
mother, but not in other individuals. Bottom, Location of the hybrid-
ization probe, u35G3.20K, is shown.
Figure 3 Interphase and metaphase FISH of family HOU542
revealed transposition of PLP1 to chromosome 19.A, Interphase FISH
using probes for PLP1 (u125A1; red) and an intrachromosomal con-
trol (RP1-39B6; green) revealed one PLP1 signal (arrowhead) ap-
pearing distant from the control signal in the mother (BAB1381). B,
In the same individual, metaphase FISH using chromosome 19-specific
probe (green) localized one copy of PLP1 (red) on 19qtel (arrowhead).
The small box shows an enlarged image of derivative chromosome
19. C, Interphase FISH of the healthy brother (BAB1380) revealed
that he also has the derivative chromosome 19 with PLP1 signal (ar-
rowhead). D, An ideogram representing insertional translocation of
PLP1 from Xq22.2 to 19qtel (red). Green signals indicate intrachro-
mosomal controls that were used in FISH analyses.
and recombination breakpoints in each family by STS-
content mapping. In family HOU542, the proximal
breakpoint occurred 47 Kb centromeric to PLP1,within
cosmid u35G3 (GenBank accession number Z93848).
STS mapping localized the proximal breakpoint within
a 1-Kb genomic interval (fig. 5). With draft genomic
sequence information about the PLP1 proximal region
used as a guide, a recombination-specific junction frag-
ment was cloned, using DOP-PCR. DNA sequencing of
this junction fragment allowed us to identify the re-
combination breakpoint and localize the distal end at
∼700 Kb telomeric to PLP1, within PAC RP3-513M9
(AL049631) (figs. 6 and 7). Deletion-specific junction
fragments were identified in the patient and his mother
with primers spanning the recombination breakpoints,
both confirming the recombination breakpoint and its
segregation in the family (fig. 5). As anticipated, no
deletion junction fragment was identified in the unaffec-
ted sibling. The deletion in HOU542 spans 750 Kb
(fig. 7).
Sequence comparison between the recombinant junc-
tion fragment and wild-type genomic sequence revealed
that the translocation event occurred between two Alu
repetitive sequences (subgroup Alu-Sq for the proximal
and Alu-Sx for the distal copies, respectively), in which
the overall sequence identity was 85% for 160 bp be-
tween proximal and distal copies (figs. 5 and 6). Perfect
sequence alignment was observed at the recombination
breakpoint for 18 bp (fig. 6). Other than these Alu se-
quences, there was no apparent homology between the
genomic regions around the two breakpoints.
In the family HOU669, STS mapping localized the
proximal breakpoint to ∼84 Kb centromeric to PLP1,
within PAC RP5-1055C14 (AL049610). Similarly, we
used DOP-PCR to span the recombinant breakpoint to
the distal end. DNA sequence of the DOP-PCR frag-
ments revealed that the distal breakpoint is located∼500
Kb telomeric to PLP1 within cosmid u240C2 (Z73497)
(figs. 5 and 6). This finding was independently confirmed
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Figure 4 Results of interphase FISH and haplotype analyses of family HOU669. A pedigree of the family HOU669 is shown, with
haplotypes at DXS8096, CA-PLP, DXS1191, and DXS8075, as well as interphase FISH images using both PLP1 (red) and control (green)
probes. The healthy sister and mother carry a deleted chromosome shown by both FISH and haplotype analyses. Neither of the maternal
grandparents revealed deletion by FISH. The haplotype analysis shows that the deletion chromosome (light yellow boxes) was derived from
the grandfather.
by STS-PCR mapping (fig. 7). Thus, this deletion spans
∼600 Kb. Junction-specific PCR amplification confirmed
the genomic interval for the deletion and segregation in
the family members (fig. 5). Sequence analysis of the
junction fragment revealed that there is no homologous
sequence between proximal and distal boundaries (fig.
6). The proximal breakpoint is embedded in a short
stretch of MIR (mammalian-wide interspersed repeats)
sequence adjacent to two contiguous Alu sequences. The
distal junction–flanking sequence contains no inter-
spersed repetitive elements for 11 Kb surrounding the
breakpoint (fig. 5). No sequence overlap was found at
the breakpoint, suggesting that the recombination was
mediated by NHEJ (fig. 6). There is an unrecognized 12-
bp sequence between proximal and distal breakpoints,
which contains an incomplete 9-bp direct repeat.
In family PMD1, STS mapping identified the proximal
breakpoint ∼30 Kb centromeric to PLP1, within cosmid
u35G3 (Z93848). The distal breakpoint mapped ∼200
Kb telomeric to PLP1 (figs. 5 and 7). DOP-PCR and
sequence analyses, however, indicated that junction se-
quences are inconsistent with the STS mapping results.
We obtained 30 bp of sequence adjacent to the proximal
breakpoint that completely matched a unique sequence
∼760 Kb telomeric to PLP1, within BAC RP11-541I12
(AL121868) in an inverted orientation (figs. 5 and 6).
There was no homology between the flanking sequences
before and after the breakpoint, other than a 2-bp over-
lap. Sequences of the junction fragment after this 30-bp
segment aligned to a region ∼640 Kb telomeric to PLP1,
within PAC RP3-513M9 (AL049631), also in an in-
verted orientation (figs. 5 and 7). PCR using primers
spanning these multiple breakpoints amplified the re-
combination specific-junction fragments that extend5
Kb further in the centromeric direction (data not shown).
No homologous sequence was identified in the region
Figure 5 STS-content PCR and junction-specific PCR analyses. Flanking genomic regions of the proximal and distal breakpoints are
shown for each family. Interspersed repeats are marked. In each region, the centromere is to the left and the telomere to the right. Recombination
breakpoints and flanking sequence are shown as thick arrows. Light gray bars represent the position of the target regions for STS-content PCR,
and the corresponding agarose gel photographs are presented. In each experiment, results for a proband (P) and a normal control (C) are shown.
Note that STS within the deleted genomic region resulted in no amplification in probands. Results of the agarose gel electrophoresis for junction-
specific PCR analyses (right) revealed amplification from patients and carriers, but not from noncarriers or normal control. Breakpoint PCR
for family PMD1 showed PCR amplification in all three individuals (two patients and one carrier mother) as well as in a normal control, using
primers flanking the recombination breakpoint, suggesting the existence of contiguous wild-type sequence of this region. We used BAB1379 as
a negative control to determine the specificity of this PCR assay.
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Figure 6 DNA sequence of recombination junction fragments. DNA sequence for each deletion-specific junction fragment obtained by DOP-
PCR was perfectly aligned to the wild-type flanking finished genomic sequences for both proximal and distal breakpoints. Alignments with the
proximal boundary were shaded in light gray, and those with the distal boundary were shaded in dark gray. Top, Sequence alignment in family
HOU542. The recombination breakpoint was embedded in an 18-bp stretch of perfect sequence alignment (shaded in black with white letters).
Middle, Sequence alignment in family HOU669. The recombination breakpoint was located within a 12-bp segment that has partial sequence
identity to proximal boundary sequence (underlined). The origin of this 12-bp segment is unknown. Bottom, Sequence alignment in family PMD1.
The sequences of the junction fragment consist of three segments (see fig. 5). In addition to the proximal and distal boundaries, a 34-bp middle
fragment is shown in black shading. This middle segment has 2-bp overlaps with proximal and distal segments, respectively (asterisks above the
alignment).
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flanking the deletion breakpoints, other than a 2-bp
overlap.
The complicated and multidirectional recombination
events—as well as the discrepancy between STSmapping
and junction fragment analyses—indicate that the chro-
mosome rearrangement in this family is complex. Ex-
perimental evidence suggests that it is not a simple de-
letion but rather is accompanied by inversion or inverted
duplication events. To examine these complex rearrange-
ments, we investigated further the genomic region ∼640
Kb telomeric to PLP1. Two possibilities were investi-
gated. First, a large inversion event between regions
∼200 Kb and ∼640 Kb telomeric from PLP1, adjacent
to the deletion, may be associated with the deletion.
Second, an inverted duplication of part or the entire
length of the same 200–640-Kb region may be involved
in the complex rearrangement.
The first possibility was examined by PCR using a set
of primers spanning the potential inversion breakpoint
at the 640 Kb region. The inversion should split the
interval of this PCR amplification; thus, no amplification
would be predicted in the case of inversion. However,
we identified amplification in two patients, H142 and
H152, as well as in the carrier female and controls (fig.
5, PMD1 breakpoint PCR). Therefore, we concluded
that inversion is unlikely.
To test the second possibility, we used interphase FISH
analysis with a 5-Kb genomic probe adjacent to the 640
Kb breakpoint. This should allow the highest resolution
to detect a relatively small inverted duplication. The in-
terphase FISH for patient H142, however, failed to de-
tect a duplicated signal (data not shown). We therefore
did not find evidence for duplication at this resolution.
Genes Contained within the Genomic Deletions
The genomic sequence of the deleted regions, includ-
ing one gap of unknown length at ∼260 Kb telomeric
to PLP1, were analyzed. Deletion breakpoints were
placed on the physical map (fig. 7). Proximal break-
points are all located within an ∼100-Kb interval be-
tween PLP1 and MRGX. There is only one predicted
gene, LOC170240, within this interval that is deleted
in family HOU669. The distance from PLP1 to each
distal breakpoint revealed larger variation in length, but
each involved two genes, RAB9L and TMSNB, in ad-
dition to PLP1.
RAB9L was identified by a similarity search, using
RAB9 sequences (Seki et al. 2000). RAB9L has three
exons spanning 7 Kb. It contains an ATP/GTP-binding
site motif A, which defines RAB9L as a member of the
RAS superfamily, but its function has not been deter-
mined. TMSNB is a member of the thymosin b family.
It spans 3.5 Kb and encodes a small (5-KDa) polypeptide
that likely binds to a monomer actin and prevents actin
polymerization (Huff et al. 2001). Deletion of TMSNB
may not be deleterious, because another copy ofTMSNB
exists ∼1.2 Mb proximal to PLP1, based on the genome
sequence annotation (data not shown). Although the se-
quence identity for the entire mRNA between these two
copies of TMSNB is only 91%, the coding sequences
are completely identical (99.7% sequence identity), ex-
cept for one silent substitution at the fourth amino acid
residue (K4K GrA12). Probably both copies are ex-
pressed, because multiple corresponding mRNA for ei-
ther gene was identified in the EST database (e.g.,
BI438503 and BC000183 for the copies on Xq22.2 and
Xq22.1, respectively).
Some predicted genes were identified within the dele-
tion intervals (fig. 7). Five copies of H2B-like genes were
identified, which are likely contained within an LCR,
LCR-PMD, described below. No matching ESTs have
been identified for these H2B-like genes. LOC1170240
was computationally predicted to encode seven exons and
337 amino acids, with significant homology to the glycine
receptor aZ2 subunit. However, no EST that aligns to this
predicted gene is identified in theGenBankdatabase.RP1-
233G16.1 spans six exons and likely encodes a
388–amino acid protein with unknown function. Three
predicted genes assigned by the Ensembl database
(ENSG00000147207, ENSG00000299903, and ENSG
00000123576) had no matching ESTs.
It appears that the genomic region distal to PLP1 con-
tains fewer genes than the proximal region. There are
only two known genes (RAB9L and TMSNB) in the ∼1-
Mb interval distal to PLP1,whereas at least eight known
genes are located within a 0.5-Mb proximal genomic
interval (fig. 7). Therefore, it is likely that deletions in-
volving large genomic segments in the proximal region
of PLP1 result in deletion of several genes, which may
be deleterious. However, each gene and the predicted
genes need to be elucidated with regard to the pheno-
typic consequence of deletion.
LCR and Its Potential Involvement in the Deletions
An analysis of the genome sequence at the telomeric
end of two deletions revealed complex genomic archi-
tecture. A large-scale genome comparison revealed a pair
of LCRs (designated LCR-PMDA and LCR-PMDB, re-
spectively) flanking the gap of the draft genome sequence
(fig. 8A). LCR-PMDA spans ∼45 Kb and contains a 13-
Kb internal segment of mostly interspersed repeat ele-
ments (194% of total length), with two inverted ho-
mologous segments (88.1% identity), designated A1a
and A2. LCR-PMDB spans ∼32 Kb with no interruption
and also contains two inverted segments, A1b and A3,
with 89.9% identity. The segments A1a and A1b share
high sequence identity (99.3%) for 120 Kb, whereas
segments A2 and A3 show 86.8% sequence identity (fig.
8B). Segment A2 has the lowest homology to other seg-
ments (87%–88%) and reveals fragmentation by inser-
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Figure 8 Genomic structure of LCR-PMDA and LCR-PMDB.
A, Flanking the gap in the draft genome sequence, two inverted repeats,
LCR-PMDA and LCR-PMDB, span 45 Kb and 32 Kb, respectively.
LCR-PMDA has an inset of a 13-Kb genomic segment that is abundant
in interspersed repeat elements (194%). Each LCR consists of two
homologous segments, designated A1a and A2 for LCR-PMDA, as
well as A1b and A3 for LCR-PMDB. B, Sequence identity analysis
among the segments, using BLAST2. Segments A1a and A1b reveal
the highest identity, whereas A2 and A3 show the lowest identity. C,
Phylogenic tree shows evolution of each segment in LCR-PMDA and
LCR-PMDB, based on the sequence identity and genomic structure.
tion/deletion events. These findings suggest that the di-
vision between segments A2 and A3 is the more ancient
event and that between A1a and A1b is the more recent
(fig. 8C).
The distal recombination breakpoint for family
HOU669 appears to be located within segment A1b of
LCR-PMDB. STS-content mapping for family PMD1
placed the distal breakpoint within LCR-PMDA. How-
ever, the information from the PCR assay was limited
because of the interference of LCR-PMDB and the high
interspersed repeat content. Although the cloning and
sequence analysis of the junction fragment revealed that
the breakpoints are not located within the LCR-PMDA,
formation of the complex genomic rearrangement in this
family may be associated with the genome architecture
involving LCR-PMDA and, possibly, LCR-PMDB.
Discussion
Genomic rearrangements play a major role in the path-
ogenesis of PMD, which defines PMD as a genomic dis-
order (Lupski 1998; Inoue and Lupski 2002). Dupli-
cations of a genomic fragment, usually 1500 Kb and
encompassing the entire PLP1 gene, account for PMD
in 60%–70% of patients (Sistermans et al. 1998; Inoue
et al. 1999). In contrast, complete deletion of PLP1 is
observed infrequently. Only one family with PLP1 de-
letion was described elsewhere (Raskind et al. 1991),
and the present study adds two new families. We ex-
plored the products of genomic recombination resulting
in PLP1 deletion and present a model for theirmolecular
mechanisms and phenotypic consequences.
Genomic Mechanisms for Chromosomal
Rearrangements Resulting in the PLP1 Deletions
The deletion of the genomic fragment that contains
the entire PLP1 gene in the two novel families described
in this study arose by at least two distinct processes: an
insertional translocation event and a sister-chromatid
exchange in male meiosis. The third family revealed a
complex genomic rearrangement; further characteriza-
tion will be required to elucidate how the recombinant
products were derived.
The insertional translocation is probably a rare event;
no such recurrent cases with similar PLP1 translocations
have been reported. However, because the size of the
translocated fragment was not visible by routine G-
banding microscopic analysis (i.e., submicroscopic),
some cases with similar recombination may have been
overlooked. Notably, there are three unrelated families
with PMD with interstitial submicroscopic PLP1 inser-
tion within the X chromosome—two in Xp22.1 and the
other in Xq26—resulting in PLP1 duplications (Hodes
et al. 2000). One of the cases was accompanied by peri-
centric inversion. Together with the interstitial translo-
cation identified in this study, this propensity for trans-
location of PLP1 suggests that the genomic region
surrounding PLP1 may contain sequence resulting in
susceptibility to transposition.
On the other hand, sister-chromatid exchange might
be more common, because deletion may be generated as
a reciprocal recombination event of the duplication. De-
spite the high frequency of PLP1 duplications as prod-
ucts of sister-chromatid exchanges, however, family
HOU669 is in fact the first reported instance of a sister-
chromatid–exchange event resulting in PLP1 deletion.
Given our observations, comparedwith duplications, de-
leted genomic segments are relatively small and probably
involve only three genes (PLP1, RAB9L, and TMSNB),
whereas duplication can be more variable in size and
can involve more genes (Inoue et al. 1999). Yet PLP1
deletion is relatively infrequent compared with PLP1
duplication. We hypothesize that the viable size for de-
letion is limited. Larger deletions might, in turn, result
in a reduced fertility or embryonic lethality, whereas du-
plication of the same segment does not. This may explain
the infrequent observation of PLP1 deletion; however,
we cannot formally exclude the possibility that dupli-
cation and deletion arise by separate mechanisms with
different frequencies.
Complex Rearrangements and NHEJ as the Mechanism
for the DNA Recombination
Molecular dissection of the PLP1 deletion–rearrange-
ment breakpoints at the DNA sequence level revealed
mechanisms for the recombination event in each family.
In family HOU542, with insertional translocation, the
DNA sequence revealed that the breakpoint is located
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within two overlapping Alu sequences in direct orien-
tation with an 18-bp perfect sequence identity at the
breakpoint. Given the observation of insertional trans-
location in the mother, the chromosome rearrangement
likely did not result from a reciprocal recombination
between two different chromosomes, but rather resulted
from a transposition of the PLP1-containing genomic
segment. Excision of the genomic segment was probably
mediated by an Alu-Alu recombination on the X chro-
mosome. No other genomic architectural features sup-
porting susceptibility for the transposition event—such
as palindromes, LCRs, or low-complexity sequence—
were found around the breakpoints. Analyses of the ma-
ternal grandparents and characterization of chromo-
some 19 breakpoints are required for precise elucidation
of the interchromosomal transposition of PLP1.
Sequence analyses of junction fragments in the other
two families revealed a complex genomic recombination.
Each of the deletion breakpoints was mapped to a dif-
ferent location; no common breakpoint was observed.
Together with the absence of homologous sequences
flanking the deleted genomic interval, it is unlikely that
nonallelic homologous recombination mediates the re-
arrangement. Our findings from the analyses of the
products of recombination are consistent with a mech-
anism of NHEJ. In both families, a small piece of DNA
sequence that does not belong to either proximal or dis-
tal flanking sequences was identified between the prox-
imal and distal breakpoints. In family HOU669, a 12-
bp fragment of unknown origin was found at the
junction. Because this 12-bp fragment consists of partial
direct repeats, it may be synthesized during the process
of double-strand break repair and NHEJ.
Family PMD1 revealed a more complex recombina-
tion event. A 30-bp short fragment was inserted at the
junction, which originated 1100 Kb away from the distal
junction. No sequence homology was found at proximal,
interstitial, or distal boundary sequences, indicating that
NHEJ likely mediated the recombination. Furthermore,
the DNA recombination likely involves a complex pro-
cess, as shown in figures 5, 6, and 7. We investigated
two possibilities—inversion or inverted duplication ac-
companied by the deletion—to explain the genomic re-
arrangement in this family. Neither a PCR assay for in-
version breakpoints nor interphase FISH revealed
evidence in support of either of these possibilities. Be-
cause these assays do not completely exclude the pos-
sibility of variant inversion or duplication, further in-
tensive genomic investigation is required to elucidate the
genomic mechanism of this complex rearrangement.
Genome Architecture Analysis of Complex LCRs
that May Instigate the Genomic Rearrangements
We identified two novel LCRs, LCR-PMDA and LCR-
PMDB, both telomeric to PLP1, flanking a gap in the
draft genome sequence. Both LCRs are likely associated
with the genomic recombination that resulted in dele-
tions in two families. These LCRs do not serve as sub-
strates for NAHR, at least in the DNA rearrangements
resulting in PLP1 deletion, but may be associated with
susceptibility to initiate DNA rearrangements, perhaps
by stimulating double-strand breaks. Involvement of
LCRs in chromosomal translocations was indicated in
chromosome 22–associated chromosomal rearrange-
ments (Spiteri et al. 2001). No unique sequence struc-
tures or homology segments were recognized at the re-
combinant breakpoints of DMD duplications (Hu et al.
1991); however, DMD rearrangement breakpoints ap-
pear to cluster (Baumbach et al. 1989), and the molec-
ular basis for the nonrandom nature of the breakpoints
has not been determined at the DNA sequence level.
These rearrangement-breakpoint hot spots may reflect
unique genome-architectural features.
Of interest, our preliminary data indicate that at least
some of the breakpoints for PLP1 duplications are also
located within the intervals that contain the LCR-PMDA
and LCR-PMDB (data not shown). As observed in other
regions of human genome, this gap may contain addi-
tional complex or repeat structures that are difficult to
clone and sequence (Eichler 2001). Further investigation
of this genomic region may clarify the molecular basis
of PLP1 duplication and deletion and a role for these
LCRs and genomic architecture in susceptibility to ge-
nomic rearrangements.
Phenotypic Consequence of PLP1 Deletions in Males
and Females
Each male patient with PLP1 deletion had a mild form
of PMD or a complicated form of spastic paraplegia type
2. In addition, two families with nonsense mutations in
exon 1, which resulted in the termination at the second
codon of PLP1 and presumably null alleles, also had a
mild form of PMD (Sistermans et al. 1996; Garbern et
al. 1997). Of note, null PLP1 results in peripheral mye-
linopathy in addition to CNS myelinopathy; peripheral
neuropathy has not been associated with other defects
of the PLP1 gene (Garbern et al. 1997). Furthermore,
in mice, Plp1 is not necessary for myelin compaction
during development (Klugmann et al. 1997; Griffiths et
al. 1998). These observations suggest a complex pa-
thology for gene dosage abnormalities at the PLP1 locus,
in which dominant-negative and loss-of-function alleles
of the PLP1 gene may result in different pathogenesis
with distinct phenotypic consequences.
Female carriers add even more complexity to the
mechanism for phenotypic manifestation because of X
inactivation. We observed symptomatic carriers with
mild late-onset spastic diplegia of varying severity in the
families with deletions. Such families with symptomatic
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carriers are mostly associated with mutations that result
in a mild phenotype but not with mutations resulting in
a severe phenotype. The cellular mechanism for this par-
adoxical presentation can be explained by mosaicism of
the oligodendrocyte population in the mild mutations
(Hudson 2001; Inoue et al. 2001b).
In family HOU542, the mother with an insertional
translocation of PLP1 from chromosome X to 19 pre-
sented with a more severe phenotype than did carrier
females in other families. On the other hand, the male
sibling who has the derivative chromosome 19, thus car-
rying two copies of PLP1,manifests no apparent clinical
phenotype, suggesting silencing of the translocatedPLP1
copy. This phenotypic presentation in the mother may
simply be explained by mildly skewed X inactivation in
the unfavorable direction (i.e., the active X chromosome
contains the deleted PLP1 allele), although it is unclear
whether X inactivation in peripheral blood reflects that
in the CNS. In addition, altered expression of PLP1 due
to the translocation, which could either increase or de-
crease expression, may be associated with the pheno-
typic manifestation. Such a change in gene expression
due to chromosomal rearrangements, referred to as a
position effect, has been observed in other human dis-
orders (reviewed in Kleinjan and van Heyningen 1998).
Two distinct mechanisms can be associated with a
position effect (Kleinjan and vanHeyningen 1998). First,
the translocation might separate upstream cis-acting reg-
ulatory elements from PLP1 exons, resulting in inap-
propriate expression of PLP1. This includes disruption
of a locus-control region, which is well-documented in
the b-globin gene (Kioussis et al. 1983). Although the
deletion in HOU542 contains 47 Kb of upstream se-
quence, which is likely enough for specific PLP1 ex-
pression (Wight et al. 1993; Ikenaka and Kagawa 1995),
it may not contain a potential locus-control region,
which is required to overcome a position effect (Milot
et al. 1996; Grosveld et al. 1987). However, a locus-
control region in PLP1 has not been identified. Alter-
natively, a portion of the genomic segment could be trun-
cated during the process of translocation. In this model,
all of the expressing cells may reveal an equally altered
level of expression. Given the equally strong FISH signals
from chromosomes X and 19 by the cosmid probe for
the PLP1 gene, a gross loss of genomic segment is
unlikely.
Second, a mechanism analogous withDrosophila me-
lanogaster position-effect variegation (PEV) may sup-
press PLP1 transcription if the translocated PLP1 is em-
bedded in the telomeric heterochromatic-repeat region
(Wakimoto 1998). When a functional copy of a eu-
chromatic gene is translocated to a heterochromatic re-
gion, the heterochromatinized state of DNA may spread
into the juxtaposed euchromatic gene, thereby silencing
the transcription (Kleinjan and van Heyningen 1998).
PEV results in a stable silencing of genes in a clonal
subpopulation of cells; thus the expression appears to
be mosaic (Festenstein et al. 1996). Such a heterochro-
matic suppression effect on a gene inserted adjacent to
telomeric repeats in human cells was experimentally ob-
served (Baur et al. 2001). Together with the mosaicism
due to the X inactivation, the PEV model may result in
significant complexity as to the PLP1 expression level
in the mother of HOU542. To date, we have obtained
no evidence to favor either mechanism. Further genomic
characterization of the position of translocation and the
cis-regulatory sequence of translocated PLP1 gene is re-
quired to address this question.
In summary, analysis of the products of recombination
in patients with PMD who harbor PLP1 deletion sug-
gests NHEJ as a predominant mechanism. Breakpoint
mapping reveals genome architecture consisting of a
complex LCR, which may result in susceptibility to re-
arrangements. Phenotypic analyses indicate that ge-
nomic rearrangement may have complex consequences
for genes that manifest dosage effects, particularly if they
are located on the X chromosome. Although many ge-
nomic disorders are mediated through homologous re-
combination mechanisms (Lupski 1998; Emanuel and
Shaikh 2001; Inoue and Lupski 2002; Stankiewicz and
Lupski 2002a, 2002b), the cases presented here suggest
that many, if not most, other genomic and chromosomal
rearrangements are mediated through sometimes very
complex but certainly distinct mechanisms, such as
NHEJ. In addition, cases like this allow for studies of
genes outside their normal chromosomal environments
and will aid in our understanding of control of gene
expression and position effects.
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